A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma

Table 1

Identification of small molecular compounds against HCC by CMap database.

CMap name	Mean		Enrichment		Specificity	Percent nonnull
DL-thiorphan	-0.847	2	-0.933	0.00926	0.0227	100
Sanguinarine	-0.864	2	-0.929	0.01036	0.0188	100
Apigenin	-0.833	4	-0.884	0.00042	0.0163	100
Quinostatin	-0.768	2	-0.882	0.02827	0.1985	100
Menadione	-0.788	2	-0.871	0.03314	0.046	100
Blebbistatin	-0.753	2	-0.862	0.03825	0.0608	100
8-Azaguanine	-0.907	4	-0.853	0.00092	0.014	100
Luteolin	-0.773	4	-0.849	0.00095	0.0114	100
Alsterpaullone	-0.771	3	-0.843	0.00773	0.1143	100
Thioguanosine	-0.785	4	-0.837	0.00125	0.0141	100
0297417-0002B	-0.759	3	-0.816	0.0124	0.0738	100
Bisacodyl	-0.736	4	-0.814	0.00221	0.0242	100
Lasalocid	0.663	4	0.801	0.00298	0.0245	100
Cefamandole	0.617	4	0.805	0.00269	0.0104	100
Ikarugamycin	0.65	3	0.817	0.0121	0.0389	100
Gly-His-Lys	0.738	3	0.822	0.0112	0.0449	100
Prestwick-691	0.711	3	0.831	0.00957	0.025	100
Heptaminol	0.745	5	0.842	0.00022	0.0121	100
Atracurium besilate	0.712	3	0.845	0.00723	0.0173	100
3-Acetamidocoumarin	0.728	4	0.853	0.0007	0	100
Thiamphenicol	0.746	5	0.855	0.00014	0.0124	100
Penbutolol	0.736	3	0.863	0.00481	0.017	100
Thapsigargin	0.674	3	0.871	0.00397	0.1401	100
Nadolol	0.737	4	0.872	0.00036	0.0055	100
Felbinac	0.733	4	0.875	0.00034	0.0117	100
Prestwick-1103	0.693	4	0.875	0.00034	0	100
Gentamicin	0.678	4	0.878	0.0003	0.0063	100
Biperiden	0.736	5	0.882	0.00006	0.0061	100
Prestwick-1082	0.713	3	0.883	0.00322	0.0158	100
Prestwick-692	0.769	4	0.913	0.00004	0.0061	100
Isoflupredone	0.874	3	0.94	0.0003	0.0052	100
Viomycin	0.861	4	0.948	0	0	100
Adiphenine	0.905	5	0.956	0	0	100